Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

257 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
Verstovsek S, Mesa RA, Gotlib J, Levy RS, Gupta V, DiPersio JF, Catalano JV, Deininger M, Miller C, Silver RT, Talpaz M, Winton EF, Harvey JH Jr, Arcasoy MO, Hexner E, Lyons RM, Paquette R, Raza A, Vaddi K, Erickson-Viitanen S, Sun W, Sandor V, Kantarjian HM. Verstovsek S, et al. Among authors: mesa ra. Br J Haematol. 2013 May;161(4):508-16. doi: 10.1111/bjh.12274. Epub 2013 Mar 11. Br J Haematol. 2013. PMID: 23480528 Free PMC article. Clinical Trial.
Thalidomide treatment in myelofibrosis with myeloid metaplasia.
Elliott MA, Mesa RA, Li CY, Hook CC, Ansell SM, Levitt RM, Geyer SM, Tefferi A. Elliott MA, et al. Among authors: mesa ra. Br J Haematol. 2002 May;117(2):288-96. doi: 10.1046/j.1365-2141.2002.03443.x. Br J Haematol. 2002. PMID: 11972510 Clinical Trial.
Adverse events after imatinib mesylate therapy.
Elliott MA, Mesa RA, Tefferi A. Elliott MA, et al. Among authors: mesa ra. N Engl J Med. 2002 Feb 28;346(9):712-3. doi: 10.1056/NEJM200202283460919. N Engl J Med. 2002. PMID: 11870257 No abstract available.
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Tefferi A, et al. Among authors: mesa ra. Blood. 2002 May 15;99(10):3854-6. doi: 10.1182/blood-2001-12-0154. Blood. 2002. PMID: 11986248 Clinical Trial.
257 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page